Quinolone Resistance Reversion by Targeting the SOS Response
Open Access
- 8 November 2017
- journal article
- Published by American Society for Microbiology in mBio
- Vol. 8 (5), e00971-17
- https://doi.org/10.1128/mbio.00971-17
Abstract
Suppression of the SOS response has been postulated as a therapeutic strategy for potentiating antimicrobial agents. We aimed to evaluate the impact of its suppression on reversing resistance using a model of isogenic strains of Escherichia coli representing multiple levels of quinolone resistance. E. coli mutants exhibiting a spectrum of SOS activity were constructed from isogenic strains carrying quinolone resistance mechanisms with susceptible and resistant phenotypes. Changes in susceptibility were evaluated by static (MICs) and dynamic (killing curves or flow cytometry) methodologies. A peritoneal sepsis murine model was used to evaluate in vivo impact. Suppression of the SOS response was capable of resensitizing mutant strains with genes encoding three or four different resistance mechanisms (up to 15-fold reductions in MICs). Killing curve assays showed a clear disadvantage for survival (Δlog 10 CFU per milliliter [CFU/ml] of 8 log units after 24 h), and the in vivo efficacy of ciprofloxacin was significantly enhanced (Δlog 10 CFU/g of 1.76 log units) in resistant strains with a suppressed SOS response. This effect was evident even after short periods (60 min) of exposure. Suppression of the SOS response reverses antimicrobial resistance across a range of E. coli phenotypes from reduced susceptibility to highly resistant, playing a significant role in increasing the in vivo efficacy. IMPORTANCE The rapid rise of antibiotic resistance in bacterial pathogens is now considered a major global health crisis. New strategies are needed to block the development of resistance and to extend the life of antibiotics. The SOS response is a promising target for developing therapeutics to reduce the acquisition of antibiotic resistance and enhance the bactericidal activity of antimicrobial agents such as quinolones. Significant questions remain regarding its impact as a strategy for the reversion or resensitization of antibiotic-resistant bacteria. To address this question, we have generated E. coli mutants that exhibited a spectrum of SOS activity, ranging from a natural SOS response to a hypoinducible or constitutively suppressed response. We tested the effects of these mutations on quinolone resistance reversion under therapeutic concentrations in a set of isogenic strains carrying different combinations of chromosome- and plasmid-mediated quinolone resistance mechanisms with susceptible, low-level quinolone resistant, resistant, and highly resistant phenotypes. Our comprehensive analysis opens up a new strategy for reversing drug resistance by targeting the SOS response.Keywords
Funding Information
- MINECO | Instituto de Salud Carlos III (PI14/00940)
- MINECO | Instituto de Salud Carlos III (PI13/00063)
- MINECO | Instituto de Salud Carlos III (REIPI RD12/0015)
This publication has 47 references indexed in Scilit:
- Antimicrobials as promoters of genetic variationCurrent Opinion in Microbiology, 2012
- Vibrio cholerae Triggers SOS and Mutagenesis in Response to a Wide Range of Antibiotics: a Route towards MultiresistanceAntimicrobial Agents and Chemotherapy, 2011
- How antibiotics kill bacteria: from targets to networksNature Reviews Microbiology, 2010
- Antibiotics for Emerging PathogensScience, 2009
- The SOS response promotes qnrB quinolone‐resistance determinant expressionEMBO Reports, 2009
- Engineered bacteriophage targeting gene networks as adjuvants for antibiotic therapyProceedings of the National Academy of Sciences of the United States of America, 2009
- Determination of Antibiotic Hypersensitivity among 4,000 Single-Gene-Knockout Mutants of Escherichia coliJournal of Bacteriology, 2008
- The frequency and structure of recombinant products is determined by the cellular level of MutLProceedings of the National Academy of Sciences of the United States of America, 2007
- A novel role for RecA under non-stress: promotion of swarming motility in Escherichia coli K-12BMC Biology, 2007
- Complete and SOS-Mediated Response of Staphylococcus aureus to the Antibiotic CiprofloxacinJournal of Bacteriology, 2007